Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024

NEW YORK, June 18 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024

http://www.reportlinker.com/p02148692/Medical-Device-Leader-Series-Top-Pre-Filled-Injection-Device-Manufacturers-2014-2024.html

Report Details

Pre-filled syringes and related devices – discover leading companies' revenue prospects
How are companies in the pre-filled syringe industry performing? Visiongain's report gives you data, analysis and discussions for producers of those drug delivery devices.
Our updated study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2024. There you see financial results, interviews, trends, opportunities and sales predictions.
That way you discover potentials of established and emerging companies. Read on to scan those organisations and see what their future market could be worth.
Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 19 top companies – and analyses that overall industry – with recent results, revenue forecasts and growth rates. There you gain 76 tables, 43 charts and two interviews. You also get qualitative analyses, including research and development (R&D). Our work lets you assess the most lucrative applications of those drug delivery technologies.

You see opportunities for biological drug makers and suppliers of medical injection devices.

That way you stay ahead in knowledge of the industry and market for these medical devices, helping your influence:
• Plastic syringes
• Glass syringes
• Related injection products and disposable (single-use) systems for injecting drugs.
And the following sections highlight what our new investigation gives you.

Company profiles – what firms hold most potential and how do they succeed?

Our report profiles 19 leading companies across four sectors of the pre-filled injection devices market. The content of each discussion differs, depending on the company.

In general, then, a profile contains the following information:
• Overview of the firm, including its history in the pre-filled injection devices market
• Discussion of the company's pre-filled injection device product or service portfolio, including main clients
• Analysis of the company's recent financial performance, for overall revenue and, where possible, pre-filled injection device sales
• Assessment of its recent developments there – e.g. acquisitions, expansions, launches and collaborations with the pharmaceutical industry
• Prospects of the company – strengths over competitors and opportunities for sales
• Prediction of revenue for the period 2014-2024 (for nine companies).
Those surveys show how product and service demand has changed in recent years, as well as explaining how those needs change from 2014.
Prospects for leading pre-filled syringe manufacturers

That study gives you discussions and financial analyses for leading developers and producers of pre-filled syringes:

• Becton, Dickinson & Co. (BD)
• Gerresheimer
• Schott
• Nipro
• Nuova Ompi
• Unilife Corporation.
There you discover what the future holds for those pharma-related medical device companies, seeing how they compare and compete. You find where the best prospects for business exist.
Suppliers and users of pre-filled injection systems will benefit from 2014. Next, our work analyses developers, producers and providers of associated technology.
Outlooks for manufacturers of pre-filled syringe components

The report shows you developments and revenue prospects for leading producers of syringe components:

• Aptar Stelmi
• Datwyler Group
• West Pharmaceutical Services.
There you explore opportunities for companies making plungers, needle shields, tip caps and related products.
Hear where the money lies. Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues likely from 2014 to 2024.

Potentials of leading pen injector and autoinjector producers

In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors:
• Haselmeier
• Owen Mumford
• SHL Group
• Ypsomed.
There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technologies and raising sales.

Contract manufacturers in that parenteral drug delivery

Our work also assesses contract manufacturing organisations (CMOs) in that field. There you explore these production service providers:
• Catalent
• Hospira One2One
• Vetter Pharma
• Baxter
• Laboratorios Farmacéuticos ROVI
• Albany Molecular Research Inc (AMRI).

So you assess competitive outlooks of CMOs. You also scan applications for biological drugs (biologics), lyophilisation and dual-chamber syringes.

Value of that market in 2018 – what's possible?

Our analysis predicts overall world revenues for those pre-filled injection devices – the drug delivery technology – will reach $5.9bn in 2018. Those sales will expand further to 2024.
Greater use of biologics and vaccines raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes and ready-to-use containment of labile drugs and other complex pharmaceuticals. The study explains.
What about applications? Incidence of diabetes and expansion of the home healthcare market stimulate demand for pre-filled drug injection products. See how and where.
So medical injection systems giving improved clinical efficacy, safety and convenience will achieve success. There you discover prospects from 2014 to 2024 for that industry.

Ways Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024 helps

In particular our new investigation gives you this knowledge:
• Profiles of 19 leading companies – assess products, services, activities, opinions and results
• Competition and opportunities – explore what affects that industry, finding what influences its sales and determines its future
• Revenues to 2024 for that market at world level – discover prospects for sales growth of the overall industry and nine of its companies.

That report assesses prospects for companies in each segment via Porter's five forces analysis. It also examines strengths, weaknesses, opportunities and threats (SWOT forces) those organisations face.

Information found nowhere else, benefiting your searches, planning and decisions

That work gives independent analysis. There you receive business intelligence found only in our report, seeing where technological and financial prospects are most rewarding.
1. Executive Summary

1.1 Overview of Findings
1.2 Structure of the Report
1.3 Research and Analysis Methods

2. The Pre-Filled Injection Devices Market, 2014-2024

2.1 What are Pre-Filled Injection Devices?
2.2 Classification of Top Pre-Filled Injection Device Manufacturers
2.2.1 Glass vs. Plastic Syringes
2.3 Pen Injectors and Auto-Injectors
2.4 Advantages and Disadvantages to Pre-Filled Injection Devices
2.5 The World Pre-Filled Injection Devices Market, 2013
2.6 Pre-Filled Injection Devices Forecast, 2014-2024
2.7 Demand is Greatest in Developed Countries
2.8 Market Drivers and Restraints

3. Leading Pre-Filled Syringe Manufacturers, 2014

3.1 Becton, Dickinson & Co (BD)
3.1.1 BD Has a Broad Pre-Filled Syringe Product Range
3.1.2 BD's Proprietary Product: BD Hypak
3.1.3 BD Neopak: BD's Latest Innovation
3.1.4 BD Sterifill
3.1.5 BD Soluvia Microinjection System
3.1.6 Uniject is a Product for Emerging Markets
3.1.7 BD Physioject: BD's Autoinjector
3.1.8 BD Vystra Disposable Pen is the Company's Latest Pre-Filled Injection System
3.1.9 BD Markets Pen Injectors for Lyophilised Drugs
3.1.10 BD's Proprietary Syringe Safety Systems
3.1.11 Outlook for BD Sales, 2010-2013
3.1.12 BD Revenues by Geographical Location, 2013
3.1.13 BD Medical's Pharmaceutical Systems: Revenue Forecast 2014-2024
3.1.14 SWOT Analysis of BD's Pre-Filled Syringes Market Potential, 2014-2024
3.2 Gerresheimer: A Leading Supplier of Glass and Plastics
3.2.1 Gerresheimer's Pre-Filled Syringe Products, 2014
3.2.2 Ready-To-Fill (RTF) Syringes
3.2.3 Gerresheimer Licensed Polymer Syringes from Taisei Kako
3.2.4 Gerresheimer Began Manufacturing Pen Injectors in 2009
3.2.5 Strong Revenue Growth for Gerresheimer, 2012-2013
3.2.6 Outlook for Gerresheimer's Pre-Filled Injection Devices Market, 2014-2024
3.2.7 SWOT Analysis of Gerresheimer's Pre-Filled Injection Devices Market Potential, 2014-2024
3.3 Schott: One of the World's Leading Manufacturers of Glass Products
3.3.1 Schott Produces over 600 Product Lines
3.3.2 Glass Syringes: syriQ
3.3.3 TopPac Polymer Syringes

3.3.4 Schott's Financial Performance, 2011-2013
3.3.5 SWOT Analysis of Schott's Pre-Filled Syringes Market Potential, 2014-2024
3.4 Nipro Corporation: A Market Leader via its MGlas Acquisition
3.4.1 Outlook for Nipro's Pre-Filled Injectables Market, 2014-2024
3.4.2 SWOT Analysis of Nipro's Pre-Filled Injectables Market Potential, 2014-2024
3.5 The Stevanato Group Among the World Leaders
3.5.1 The Glass Division Includes Nuova Ompi
3.5.2 Nuova Ompi: A Pre-Filled Syringe Specialist
3.5.2.1 EZ-Fill Syringes
3.5.2.2 Extra High Quality (XQ) Syringes
3.5.2.3 Investment in New Mexican Facility
3.5.3 SWOT Analysis of Nuova Ompi's Pre-Filled Syringes Market Potential, 2014-2024
3.6 Unilife Corporation
3.6.1 Pre-filled Syringes for Reconstitution
3.6.2 Autoinjectors: RITA and LISA
3.6.3 Novel Delivery Technologies
3.6.4 Unilife Settles Supply Agreements with Pharma Giants to Improve Market Presence
3.6.5 How Will Unilife Grow over the Forecast Period?
3.6.6 SWOT Analysis of Unilife's Market Potential, 2014-2024
3.7 Pre-Filled Syringe Manufacturers: Porter's Five Forces Analysis, 2014-2024
3.7.1 Rivalry Among Competitors
3.7.2 Manufacturers Striving to Improve Safety Systems
3.7.3 Increasing Product Portfolio Diversity
3.7.4 Threat of New Entrants
3.7.5 Power of Suppliers
3.7.6 Power of Buyers
3.7.7 Threat of Substitutes

4. Leading Pre-Filled Syringe Component Manufacturers, 2014

4.1 Aptar Stelmi: A Pharma Packaging Specialist
4.1.1 Aptar Stelmi's Pre-Filled Syringe Components, 2014
4.1.2 Rigid Needle Shields
4.1.3 Company Acquired Oval Medical to Include Autoinjectors
4.1.4 Financial Progress, 2014-2024
4.1.5 What Are the Strengths and Weaknesses of Aptar Stelmi in the Pre-Filled Syringes Market?
4.2 The Datwyler Group
4.2.1 Datwyler's Pre-Filled Syringe Components, 2014
4.2.2 Omniflex Coating: Alternative to Silicone
4.2.3 Expansion of FirstLine Range
4.2.4 The Sealing Solutions Division
4.2.4.1 Demand from Vaccine and Insulin Manufacturers Driving Growth
4.2.5 Outlook of Datwyler's Pharma Packaging Division, 2014-2024
4.2.6 SWOT Analysis of Datwyler's Pre-Filled Syringe Business: Market Potential, 2014-2024
4.3 West Pharmaceutical Services
4.3.1 West's Packaging Systems
4.3.2 West's Delivery Systems
4.3.2.1 Daikyo CZ: The First Silicone-Free Polymer Syringe
4.3.2.2 SmartDose: A Novel Patch Injector
4.3.3 West Also Develops Autoinjectors and Self Injectors
4.3.4 MixJect: Addressing Lyophilised Drugs
4.3.5 West's Financial Performance in 2013
4.3.6 Outlook for West's Pre-Filled Syringes Market, 2014-2024
4.3.7 SWOT Analysis of West's Pre-Filled Syringe Market Potential, 2014-2024
4.4 Pre-Filled Syringe Component Manufacturers: Porter's Five Forces Analysis, 2014-2024
4.4.1 Rivalry Among Competitors
4.4.1.1 Emerging National Markets Will Become More Important
4.4.2 Threat of New Entrants
4.4.3 Power of Suppliers
4.4.4 Power of Buyers
4.4.5 Threat of Substitutes

5. Leading Pre-Filled Syringe Contract Manufacturers, 2014

5.1 Catalent: The World's Leading CMO
5.1.1 High Pre-Filled Syringe Contract Manufacturing Capabilities
5.1.2 Outlook for Catalent's Pre-Filled Syringes Services, 2014-2024
5.1.3 SWOT Analysis of Catalent's Contract Pre-Filled Syringe Filling Potential, 2014-2024
5.2 Hospira One2One Offers Contract Manufacturing Services
5.2.1 Hospira's Pre-Filled Syringes, 2014
5.2.2 Speciality Injectable Pharmaceuticals is the Largest Division
5.2.3 Outlook for Hospira's Contract Manufacturing Services, 2014-2024
5.2.4 SWOT Analysis of Hospira One2One Market Potential, 2014-2024
5.3 Vetter Pharma
5.3.1 An Injectable Manufacturing Specialist
5.3.2 Vetter Expands in The US and Germany
5.3.3 SWOT Analysis of Vetter's Contract Pre-Filled Syringe Filling Capacitates, 2014-2024
5.4 Baxter Has its Own CMO
5.4.1 BioPharma Solutions
5.4.2 SWOT Analysis of BioPharma Solution's Services, 2014-2024
5.5 Laboratorios Farmacéuticos ROVI
5.5.1 ROVI's Pre-Filled Syringe Capabilities, 2014
5.5.2 SWOT Analysis of ROVI's Contract Manufacturing Potential, 2014-2024
5.6 Albany Molecular Research Inc (AMRI)
5.6.1 AMRI's Financial Performance in 2013
5.6.2 SWOT Analysis of AMRI's Contract Manufacturing Services, 2014-2024
5.7 Porter's Five Forces Analysis of Pre-Filled Syringe Contract Manufacturers, 2014-2024
5.7.1 Rivalry Among Competitors
5.7.2 Threat of New Entrants
5.7.3 Power of Suppliers
5.7.4 Power of Buyers
5.7.5 Threat of Substitutes

6. Leading Pen Injectors and Autoinjector Manufacturers, 2014

6.1 Ypsomed: Diabetes Specialists for over 25 Years
6.1.1 Yposomed's Long List of Pen Injectors and Autoinjectors, 2014
6.1.2 YpsoPen: A Reusable Insulin Pen
6.1.3 ServoPen
6.1.4 UnoPen Range
6.1.5 LyoTwist Injectors for Lyophilised Drugs
6.1.6 Ypsomed Markets Two Autoinjectors
6.1.7 VarioJect
6.1.8 Ypsomed Outlook, 2014-2024
6.1.9 What Are Ypsomed's Strengths and Weaknesses?
6.2 Haselmeier: A Specialist in Self-Injection Devices
6.2.1 Axis Pen Systems
6.2.2 i-Pen: Haselmeier's Lead Product
6.2.3 Penlet Used For the Administration of Enoxaparin
6.2.4 The SoftPen Platform
6.2.5 SWOT Analysis of Haselmeier's Injectables Market Potential, 2014-2024
6.3 SHL Group
6.3.1 Divisions and Activities of that Company
6.3.1.1 A Broad Product Portfolio, 2014
6.3.1.2 Amber Autoinjector: SHL's Later Innovation
6.3.1.3 Molly Autoinjector
6.3.1.4 DAI Series Most Successful
6.3.2 SHL Group Continues to Grow in Taiwan
6.3.3 SWOT Analysis of SHL Group's Market Potential, 2014-2024
6.4 Owen Mumford
6.4.1 Autoinjector and Pen Injector Overview
6.4.2 The Autopen Series
6.4.3 Unifine Pentips for Improved Comfort
6.4.4 How Does Owen Mumford Compete?
6.4.5 SWOT Analysis of Owen Mumford's Market Potential, 2014-2024
6.5 Porter's Five Forces Analysis of the Pen Injector and Autoinjector Manufacturers, 2014-2024
6.5.1 Rivalry Among Competitors
6.5.2 Threat of New Entrants
6.5.3 Power of Suppliers
6.5.4 Power of Buyers
6.5.5 Threat of Substitutes

7. Research Interviews

7.1 Interview with Simon Williams, Business Development at Duoject Medical Systems, Quebec, Canada
7.1.1 The Current Pre-Filled Injectables Market
7.1.2 What Does Duoject Offer?
7.1.3 Pre-Filled Syringes Will Continue to Dominate the Market
7.2 Interview with a Respondent from a Leading Company in the Pre-Filled Injection Devices Market
7.2.1 The Potential of the Pre-Filled Injections Market
7.2.2 Changing Demands

8. Conclusions

8.1 The Pre-Filled Injection Devices Market in 2013
8.2 Leading Pre-Filled Injection Device Manufacturers in 2014
8.3 The World Pre-Filled Injection Devices Market: Predictions to 2024
8.4 Outlook for the Pre-Filled Injection Device Manufacturers 2014-2024
8.4.1 Emerging Countries Will Play Pivotal Role
8.5 Future of the Pre-Filled Injection Device Manufacturers Market

List of Tables

Table 2.1 Pre-Filled Injection Devices: Sub-Market Revenues ($m), Units (m), 2013
Table 2.2 Pre-Filled Injection Devices: Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 2.3 Pre-Filled Injection Devices: Revenue Forecasts by Segment ($m, CAGR %, Market Share %), 2013, 2018, 2024
Table 2.4 Pre-Filled Injection Devices Market by Region: Revenues ($m) and Market Shares (%), 2013
Table 3.1 BD: Key Facts, 2014
Table 3.2 BD Segments and Products, 2014
Table 3.3 BD Revenues by Segment ($m), 2010-2013
Table 3.4 BD Medical: Revenues by Segment ($m), 2010-2013
Table 3.5 BD: Pharmaceutical Systems Forecast, Revenue ($m), AGR (%), CAGR (%), 2013-2024
Table 3.6 BD Injection Devices: SWOT Analysis 2014-2024
Table 3.7 Gerresheimer: Key Facts, 2014
Table 3.8 Gerresheimer Segments and Products, 2013
Table 3.9 Restructured Gerresheimer Segments, 2014
Table 3.10 Gerresheimer Segments Revenues ($m), 2012, 2013
Table 3.11 Gerresheimer Pre-filled Injection Systems: Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 3.12 Gerresheimer Injection Devices: SWOT Analysis 2014-2024
Table 3.13 Schott: Key Facts, 2014
Table 3.14 Schott: Revenues ($m), 2011-2013
Table 3.15 Schott: Revenue Breakdown by Region ($m) with Revenue Share, 2013
Table 3.16 Schott Pre-filled Injection Devices: SWOT Analysis, 2014-2024
Table 3.17 Nipro: Key Facts, 2014
Table 3.18 Nipro: Revenues ($m), 2011-2013

Table 3.19 Nipro: Revenue Breakdown by Region ($m) with Revenue Share, 2013
Table 3.20 Nipro Pre-filled Injection Devices: SWOT Analysis, 2014-2024
Table 3.21 Stevanato Group: Key Facts, 2014
Table 3.22 Stevanato Group's Glass Division: Breakdown by Companies, 2014
Table 3.23 Nuova Ompi Pre-filled Injection Devices: SWOT Analysis, 2014-2024
Table 3.24 Unilife: Key Facts, 2014
Table 3.25 Unilife: Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 3.26 Unilife: SWOT Analysis, 2014-2024
Table 3.27 Pre-Filled Syringes: Leading Product Comparisons, 2014
Table 3.28 Leading Pre-Filled Syringe Manufacturers: Comparative Product Ranges, 2014
Table 4.1 Aptar Stelmi: Key Facts, 2014
Table 4.2 Aptar Stelmi: Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 4.3 Aptar Stelmi: SWOT Analysis, 2014-2024
Table 4.4 Datwyler Group: Key Facts, 2014
Table 4.5 Datwyler Group: Sealing Solutions Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 4.6 Datwyler Group: SWOT Analysis, 2014-2024
Table 4.7 West Pharmaceutical Services: Key Facts, 2014
Table 4.8 West Pharmaceuticals: Revenue Breakdown by Division ($m), 2012-2013
Table 4.9 West Pharmaceuticals: Pre-filled Injection Devices Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 4.10 West Pharmaceuticals: SWOT Analysis, 2014-2024
Table 5.1 Catalent: Key Facts, 2014
Table 5.2 Catalent: Revenue Breakdown by Division ($m, Revenue Share %), 2013
Table 5.3 Catalent: Revenue Breakdown by Division ($m, AGR %), 2012-2013
Table 5.4 Catalent: Pre-filled Injection Devices Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 5.5 Catalent: SWOT Analysis, 2014-2024

Table 5.6 Hospira: Key Facts, 2014
Table 5.7 Hospira: Revenue Breakdown by Division ($m, AGR %), 2012-2013
Table 5.8 Hospira: Pre-filled Injection Devices Revenue Forecast ($m, AGR %, CAGR %), 2013-2024
Table 5.9 Hospira: SWOT Analysis, 2014-2024
Table 5.10 Vetter Pharma: Key Facts, 2014
Table 5.11 Vetter Pharma: SWOT Analysis, 2014-2024
Table 5.12 Baxter: Key Facts, 2014
Table 5.13 Baxter: Revenue Breakdown by Division ($m, AGR %), 2011-2013
Table 5.14 Baxter's BioPharma Solutions: SWOT Analysis, 2014-2024
Table 5.15 Laboratorios Farmacéuticos ROVI: Key Facts, 2014
Table 5.16 ROVI: SWOT Analysis, 2014-2024
Table 5.17 AMRI: Key Facts, 2014
Table 5.18 AMRI: CM Revenue Breakdown by Division ($m, AGR %), 2012-2013
Table 5.19 AMRI: SWOT Analysis, 2014-2024
Table 6.1 Ypsomed: Key Facts, 2014
Table 6.2 Ypsomed Product Portfolio, 2014
Table 6.3 Selected Pharmaceutical Partners for Ypsomed's Pen Injectors, 2014
Table 6.4 Ypsomed: Revenue ($m) by Segment, 2010-2013
Table 6.5 Ypsomed: Delivery Devices Forecast, Revenue ($m), AGR (%), CAGR (%), 2013-2024
Table 6.6 Ypsomed Injection Devices: SWOT Analysis, 2014-2024
Table 6.7 Haselmeier: Key Facts, 2014
Table 6.8 Selected Partners for the i-Pen, 2014
Table 6.9 Haselmeier: SWOT Analysis, 2014-2024
Table 6.10 SHL Group: Key Facts, 2014
Table 6.11 SHL Group Product Portfolio, 2014
Table 6.12 SHL Group: SWOT Analysis, 2014-2024
Table 6.13 Owen Mumford: Key Facts, 2014
Table 6.14 Owen Mumford: SWOT Analysis, 2014-2024
Table 6.15 Other Pen Injectors and Autoinjector Manufacturers, 2014
Table 8.1 Pre-Filled Injection Devices Market: Overall Revenue Forecast by Submarkets ($m), and Market Shares (%), 2013, 2018 and 2024

List of Figures

Figure 2.1 Pre-Filled Injection Devices: Sub-Market Shares (%), 2013
Figure 2.2 Pre-Filled Injection Devices: Sub-Market Revenues ($m) and Units (m), 2013
Figure 2.3 Pre-Filled Injection Devices: Revenue Forecast ($m), 2013-2024
Figure 2.4 Pre-Filled Injection Devices: Submarket Revenue Forecasts by Segment ($m), 2013, 2018, 2024
Figure 2.5 Pre-Filled Injection Devices: Sub-Market Shares (%), 2018
Figure 2.6 Pre-Filled Injection Devices: Sub-Market Shares (%), 2024
Figure 2.7 Pre-Filled Injection Devices Market Shares by Region (%), 2013
Figure 2.8 Pre-Filled Injection Devices Market: Drivers and Restraints, 2014-2024
Figure 3.1 BD Revenues by Segment ($m), 2010-2013
Figure 3.2 BD Segments by Market Share (%), 2013
Figure 3.3 BD Medical Revenues by Segment ($m), 2010-2013
Figure 3.4 BD Medical Segments by Market Share (%), 2013
Figure 3.5 BD Revenues by Geographical Location ($m) and Revenue Shares (%), 2012-2013
Figure 3.6 BD Pharmaceutical Systems: Forecast, Revenue ($m), 2013-2024
Figure 3.7 Gerresheimer Pharmaceutical Systems Revenue ($m), 2012-2013
Figure 3.8 Gerresheimer Pre-filled Injection Systems: Revenue Forecast ($m), 2013-2024
Figure 3.9 Schott: Revenue ($m), 2011, 2012, 2013
Figure 3.10 Schott: Revenue Breakdown by Region ($m) and Revenue Share, 2013
Figure 3.11 Nipro: Revenues by Segment ($m), 2013
Figure 3.12 Nipro: Revenue Breakdown by Region ($m) and Revenue Share, 2013
Figure 3.13 Unilife: Revenue Forecast ($m), 2013-2024
Figure 3.14 Porter's Five Forces Analysis of Pre-Filled Syringe Manufacturers, 2014-2024
Figure 4.1 Aptar Stelmi: Revenue Shares ($m, %), 2013
Figure 4.2 Aptar Stelmi: Revenue Forecast ($m), 2013-2024
Figure 4.3 Datwyler Group: Sealing Solutions Division Revenues ($m), 2012-2013
Figure 4.4 Datwyler Group: Sealing Solutions Division Revenue Forecast ($m), 2013-2024
Figure 4.5 West Pharmaceuticals: Revenue Breakdown by Division ($m, AGR %) 2012-2013
Figure 4.6 West Pharmaceuticals: Breakdown by Revenue Share (%), 2013
Figure 4.7 West Pharmaceuticals: Pre-filled Injection Devices Revenue Forecast ($m), 2013-2024
Figure 4.8 Porter's Five Forces Analysis of Pre-Filled Syringes Component Manufacturers, 2014-2024

Figure 5.1 Catalent: Breakdown by Revenue Share (%), 2013
Figure 5.2 Catalent: Revenue by Division ($m), 2012-2013
Figure 5.3 Catalent: Pre-filled Injection Devices Revenue Forecast ($m), 2013-2024
Figure 5.4 Hospira: Breakdown by Revenue Share ($m), 2013
Figure 5.5 Hospira: Pre-filled Injection Devices Revenue Forecast ($m), 2013-2024
Figure 5.6 Baxter: Revenue Shares ($m, %), 2013
Figure 5.7 Baxter: BioPharma Solutions Revenues ($m), 2011-2013
Figure 5.8 AMRI: Revenue Breakdown by Division ($m), 2012-2013
Figure 5.9 Porter's Five Forces Analysis of Pre-Filled Syringes Contract Manufacturers, 2014-2024
Figure 6.1 Ypsomed Revenue ($m) by Segment, 2010-2013
Figure 6.2 Ypsomed: Pre-filled Syringes Revenue ($m) Forecast, 2013-2024
Figure 6.3 Porter's Five Forces Analysis of Pen Injector and Auto-Injector Manufacturers, 2014-2024
Figure 8.1 Pre-Filled Injection Devices Market: Overall Revenue Forecasting with Submarket ($m), 2013, 2018 and 2024

Companies Listed

Abbott Laboratories
AbbVie
Actavis (formerly Watson Pharmaceuticals)
Aflamtic (part of Stevanato Group)
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Albany Molecular Research (AMRI)
American Stelmi
American Stelmi (part of Aptar Stelmi)
Amgen
Amylin Pharmaceuticals
Antares Pharma
Aptar Stelmi (part of Aptargroup)
AptarGroup
AstraZeneca
B. Braun Medical
Baxter BioPharma Solutions (part of Baxter)
Baxter International
Bayer
BD Medico

Becton, Dickinson and Company (BD)
Berlin-Chemie (part of Menarini Group)
Bespak Injectables (formerly The Medical House)
Biocon
Biogen Idec
Blackstone Group
Bristol-Myers Squibb
Cambridge Consultants
Cardinal Health
Carl Zeiss Foundation
Catalent
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Daikyo Seiko
Datwyler
DiaExpert
Disetronic Group (part of Roche)
Dong-A Pharmaceutical
Dongbao
Duoject Medical Systems
DuPont

Elcam Medical
Eli Lilly
European Commission
European Medicines Agency (EMA)
Ferring Pharmaceuticals
Food and Drug Administration (FDA) [US]
Future Injection Technologies
Genentech (part of Roche)
Gerresheimer
GlaxoSmithKline (GSK)
Hankook Sealtech
Haselmeier
Hikma Pharmaceuticals
Hospira
Hospira One2One (part of Hospira)
Hyaluron Contract Manufacturing (HCM, part of AMRI)
Incepta Pharmaceuticals
Insulet
International Diabetes Federation Europe (IDF)
Jabil Circuit
Janssen Biotech (part of J&J)
Johnson & Johnson (J&J)
Korea Food and Drug Administration (KFDA)
Laboratorios Farmacéuticos ROVI
LifeScan
Lupin Limited
Maxxon
McKesson

Medical Glass (part of Stevanato Group)
Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]
MedImmune
Medimop Medical Projects (part of West Pharmaceutical Services)
Menarini Group
Merck Serono
Merck & Co.
Merck KGaA
MG Sterile Products (part of Nipro)
MGlas (part of Nipro)
Ministry of Health, Labor and Welfare (MHLW) [Japan]
MJ Biopharma
Mylife DiabetesCare
National Institute for Health and Care Services (NICE)
Neutral Glass and Allied Industries
Nipro Europe (part of Nipro)
Nipro Medical Corporation
Nipro MGlass (part of Nipro)
Novartis
Novo Nordisk

Nuova Ompi
Nycomed (part of Takeda)
Nypro
Occupational Safety and Health Administration (OSHA) [US]
Ompi of America (part of Stevanato Group)
Optrel (part of Stevanato Group)
OrbiMed
Oval Medical
Owen Mumford
PA Consulting Group
PATH
Pema Holding
Pfizer
Pharma-Pen (part of West Pharmaceutical Services)
Pharmstandard
Phillips Medisize
Plastef Investissements
Polfa-Tarchomin
Primequal
Revolutions Medical
RevVac
Rexam
Roche
ROVI CM (part of Laboratorios Farmacéuticos ROVI)
Safety Syringes (part of BD)
Sandoz (part of Novartis)
Sanex Packaging Connections

Sanofi
Sanofi Pasteur
Savient Pharmaceuticals
Schering-Plough (part of Merck & Co.)
Schott
Schott Kaisha
Sentry BioPharma Services
Shanghai Fosun Pharmaceutical
SHL Group
Spami (part of Stevanato Group)
Square Pharmaceuticals
Stallergenes

Stelmi Asia (part of Aptar Stelmi)
Stevanato Group
Sungwon Medical
Swedish Orphan Biovitrum (Sobi)
Taisei Kako
Teva Pharmaceutical Industries
The Tech Group (part of West Pharmaceutical Services)
Tonghua Dongbao Pharmaceutical
Triveni Polymers
UCB
Unilife Corporation
US Agency for International Development
Vetter Pharma
West Company Mexico
West Pharmaceutical India Packaging Private (part of West Pharmaceutical Services)
West Pharmaceutical Services
Wockhardt
World Health Organization (WHO)
YDS Ypsomed Delivery Systems
Ypsomed
Zeon Corporation
Zhongding Sealtech

To order this report: Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024
http://www.reportlinker.com/p02148692/Medical-Device-Leader-Series-Top-Pre-Filled-Injection-Device-Manufacturers-2014-2024.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker